2014 Taiwan Delegation Company Participants

Transcription

1 2014 Taiwan Delegation Company Participants (BIO International Convention Exhibitors) PharmaEssentia Address: 13F, No. 3, Park Street, NanKang District, Taipei 115, Taiwan (Nangang Software Park) Website: PharmaEssentia Corporation is a pharmaceutical company established by a group of Taiwanese-American scientists. Headquarter is located at NanKang Science Park in a 20-story building where we occupy the 13th and 19th floors. With the extensive foundation, we persevere as a fully integrated biopharmaceutical company, by creating and providing products to improve the quality of life for patients suffering from various diseases. Our mission is to discover, develop, and bring to the market efficacious, safe and cost-effective therapeutic products for human disease. PharmaEssentia has recently completed the construction of a cgmp biologics production plant in Taiwan to produce clinical trial quantities of the drug for these Phase III studies. The plant is expected to soon receive certification from the TFDA, EMA and FDA. Yeastern Biotech Address: 6F-3, 23 Lane 169, Kang Ning St., Shijr, Taipei 22180, Taiwan. Website: Yeastern Bioyech Co., Ltd. (YB) was founded in 2000 with the goal of providing the intelligent technical services and high quality products for life sciences research and the biomedical industry. We believe that a scientist s greatest help comes from fellow scientist. Therefore, our innovative interdisciplinary research team with highly qualified experts in different fields offers ODM or OEM research-only reagents and kits as well as diagnostic products.

2 Microbio Address: 14 F-1, No. 3, Park St., Taipei 115, Taiwan Website: Microbio was founded in May, Since its inception, the company followed its mission of caring for human life & commitment to develop innovative new drugs. Based on the concept of standardization in pharmaceutical manufacturing, and combined with the principle of scientific verification, thorough safety monitoring and quality control to ensure product efficacy, the company has successfully developed several products with the use of microbial technology platforms. Based on the management philosophy of honesty, innovation and caring, Microbio, together with its subsidiaries Oneness Biotech and Fountain Biopharma, establishes an affiliation to exploit each company s strength in different areas of biopharmaceutical R&D and to strengthen the financial resources and capability for the new drug development. Taiwan Liposome Company Address: 2F, No. 3 Yuanqu Street, Nangang District, Taipei 11503, Taiwan Website: Taiwan Liposome Company (TLC) is a biopharmaceutical company focused on the research, development and commercialization of innovative pharmaceutical products based on our proprietary drug delivery technologies. Our strengths lie in the application of lipid-based nanoparticles formulations to optimize drugs pharmacokinetics. Our technologies are particularly adapt at extending products lifecycle and managing solubility and toxicity issues, resulting in commercial-scale launches of nanoparticle injectable products. General Biologicals Address: No. 6, Innovation First Road, Hsinchu Science Park, Hsinchu 30076, Taiwan, R.O.C. Website: General Biologicals Corp. (GBC), founded in 1984, is the industry-leading in-vitro diagnostic device manufacturer in Taiwan. GBC is certified with IVD Class III, GMP and ISO 13485:2003. GBC has offices in Taipei, Hsin-Chu, Kaohsiung (Taiwan), Irvine (USA), and Vancouver (Canada). GBC has developed a wide spectrum of technology platform in various diagnostics products such as Raw Materials (antibody & antigen), Radioimmunoassay (RIA), Enzyme-linked Immunoassay

3 (ELISA), Point-of-Care Test (POCT) and Real-Time Polymerase Chain Reaction (RT-PCR). In addition, GBC has its own intensive sequential vertical technology platform of hybridoma techniques, cell culture, genetic engineering, protein purification and peptide synthesis, assay, coating, fill-in and labeling. Taiwan Fu Shrimp Enterprise Address: No.1, Yuanxi 2nd Rd., Changzhi Township, Pingtung County 908, Taiwan (R.O.C.) Website: Fu Shrimp is an ornamental shrimp export and import company that has been operating for over 6 years. Fu Shrimp began in 2006 as a fledging breeding in China, Xiamen. Fu Shrimp have grown into an international exporter of ornamental shrimp. To commit you could get best quality shrimps, we are licensed to breed shrimps and import and export ornamental shrimps under the rules of Taiwan Animal protection. Currently, our clients are come from different regions and countries which include USA, Europe, China, Japan, Korea and the rest of the world. Sunmax Address: No.10, Lane 31, Sec. 1, Huandong Rd., Tainan Science Industrial Park, Tainan County, Taiwan, R.O.C Website: Sunmax Biotechnology Co., Ltd is one of the leading medical device companies which specialize in high quality and reliable production of biomedical grade collagen and its application in the field of aesthetic, dentistry, orthopedics and skincare products. Founded in year 2001, with technology out of the benchmarking collagen experts from United States, Sunmax has grown a highly recognized, public-listed biomedical company. Sunmax Biotechnology focuses its collagen-related R&D efforts on biomedical materials, ranging from atelocollagen dermal filler, dental membrane and plug, bone graft matrix to skincare products. And through our exclusive purification platform, the derived collagen is intact with triple-helical structure for complete bioactive functionality and highly biocompatible to human. Sunmax has successfully received product approval from EU CE mark, Taiwan FDA as well as China SFDA. Equipped with GMP facilities and complying with rigorous quality-control standards of ISO13485, Sunmax Biotechnology is committed to produce an array of high-quality and reliable biomedical device products. Sunmax is dedicated to help physicians and professionals around the globe to enhance their patience s quality of life and having more and more people to benefit from our innovations in the field of collagen regeneration.

4 Cyto-Biotech Address: 9F-1, No.32, Sec. 1, Chenggong Rd., Nangang Dist., Taipei City 115, Taiwan (R.O.C.) Website: Cyto Biotech INC., established in December 2007 and focusing on the development of animal health care product, had been approved to provide the feed supplement of piglet, which had proved to have specific effect on enhancing the survival rate and the weight of piglet. The developing animal medicine of Cyto biotech, Inc. had determined as a new drug for animal by council of agriculture, which would make Cyto biotech, Inc. to become the first domestic company that entitled as a candidate to be the biotech drug company of animal medicine in January OBI Pharma Address: Ste W1907, 19F, #3, Park St, Nankang Software Park, Taipei, 11503, TAIWAN Website: OBI Pharma, Inc., was founded in Its focus is on the "Unmet Medical Needs" in challenging diseases throughout the world, such as Cancer & Infectious Diseases. OBI strives to improve health and the quality of life through innovative and cost-effective therapeutics. OBI's core competence is its R&D expertise in developing novel cancer and infectious disease therapies. The company uses its proprietary OPopS drug discovery platform to build a ground-breaking pipeline. OBI also works in close collaboration with prestigious research institutes, including Academia Sinica of Taiwan and the Memorial Sloane-Kettering Cancer Center of the US. Simpson Biotech Address: 1-1 Wen Min 2nd Street, Kuei Shan, Taoyuan, Taiwan, ROC Website: Simpson Biotech Co (SBC), a bio-fermentation company, has developed an extremely cost-effective oral-delivery recombinant protein purification platform using Starch-Binding Protein as Affinity Tag. SBC s platform significantly reduces the production costs of recombinant proteins, biologics, and industrial enzymes by improving purification processes. SBC has also commercialized the fermented mycelia of medicinal fungus for use as a dietary supplement and has conducted early stage drug discovery for an anti-inflammatory compound call HepasimR

5 isolated from these fungal mycelia. SBC won numerous awards including 3 Taipei Biotech Awards and the National Innovation Award from the government of Taiwan. Currently, SBC holds 24 patents with another 40 pending globally. SBC has built up significant expertise in microbial and enzymatic processes for value-added agriculture, food, health, and industrial applications. With experienced researchers and scale-up facilities, SBC has the capability to produce competitive recombinant proteins, therapeutic proteins, and large-scale industrial enzymes. Health Ever Biotech Address: 11F-9, No. 186, SEC 4, Nanjing E. Road Taipei, Taiwan Website: Health Ever Biotech Co., Ltd. (HEB) was established to focus on the unique botanical products backed with scientific and medical evidences. HEB is committed to researching and developing innovative new botanical drug products for today s great unmet medical needs. With in-house ISO/IEC certified laboratory, HEB has been actively involved in the preclinical and clinical development of new botanical drugs that have been verified effective and safe on animal, cellular and human studies. HEB has built a network of domestic and international senior advisors and consultants who are top-notch in the industry to maximize the success and quality of our pipeline. HEB endeavors to supply the best quality botanical drug products and makes strenuous efforts to improve the health of our compatriots. HEB is based in Taipei, Taiwan, with branch offices in United States, Canada and China. Founded Biopharma Address: 19F-1, No.3, YuanQu St., NanKang District, Taipei, 115 Taiwan, R.O.C. Website: Founded in December 2010 and headquartered in the Nankang Software Park, Taipei, Taiwan, Fountain Biopharma is focused on innovative development of humanized monoclonal antibodies for allergic and cancer diseases. The company has instituted needed core technologies for antibody drug discovery and development including fully human antibody phage display, screening bioanalytics, and antibody-guided delivery through collaboration with several leading academic institutes. Bringing upfront three antibody-based project plans Fountain Biopharma welcomes strategic collaboration partners to join advancing the development process. Our goals have been: First, to develop the anti-cancer antibody fragment (scfv)-guided cmet-liposome drug; Second,to develop for China market the biosimilar Xolair for asthma/allergy; and three, to develop anti-cεmx antibody for asthma/allergy.